ArticleBlood advances2017
EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT.
Akil A Merchant et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleBlood advances2017
Akil A Merchant et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.